miR-126 inhibits cell growth, invasion, and migration of osteosarcoma cells by downregulating ADAM-9

Tumor Biology

Volumn 35, Issue 12, 2014, Pages 12645-12654

  Jiang, Liangdong ^a   He, Aiyong ^a   Zhang, Qing ^a   Tao, Cheng ^a  

^a CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

A disintegrin and metalloprotease 9 (ADAM 9); MicroRNA 126; Osteosarcoma

Indexed keywords

ADAM 9 PROTEIN; ADAM PROTEIN; MICRORNA 126; SMALL INTERFERING RNA; UNCLASSIFIED DRUG; ADAM9 PROTEIN, HUMAN; MEMBRANE PROTEIN; MICRORNA; MIRN126 MICRORNA, HUMAN;

3' UNTRANSLATED REGION; ADULT; ARTICLE; BONE TISSUE; CANCER INHIBITION; CARCINOGENESIS; CELL GROWTH; CELL INVASION; CELL MIGRATION; CONTROLLED STUDY; DISTANT METASTASIS; DOWN REGULATION; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; LUCIFERASE ASSAY; MALE; OSTEOSARCOMA; OSTEOSARCOMA CELL; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UPREGULATION; AGED; BINDING SITE; BONE TUMOR; CANCER STAGING; CELL MOTION; CELL PROLIFERATION; CHEMISTRY; GENE EXPRESSION REGULATION; GENE SILENCING; GENETICS; METASTASIS; MIDDLE AGED; NUCLEOTIDE SEQUENCE; PATHOLOGY; RNA INTERFERENCE; TUMOR CELL LINE;

ADAM PROTEINS; ADULT; AGED; BASE SEQUENCE; BINDING SITES; BONE NEOPLASMS; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; DOWN-REGULATION; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE KNOCKDOWN TECHNIQUES; HUMANS; MALE; MEMBRANE PROTEINS; MICRORNAS; MIDDLE AGED; NEOPLASM METASTASIS; NEOPLASM STAGING; OSTEOSARCOMA; RNA INTERFERENCE;

EID: 84925283601     PISSN: 10104283     EISSN: 14230380     Source Type: Journal    
DOI: 10.1007/s13277-014-2588-3     Document Type: Article

References (25)

1. Kager L, Potschger U, Bielack S. Review of mifamurtide in the treatment of patients with osteosarcoma. Ther Clin Risk Manag. 2010;6:279–86.
2. Wolfsberg TG, Primakoff P, Myles DG, White JM. Adam, a novel family of membrane proteins containing a disintegrin and metalloprotease domain: multipotential functions in cell-cell and cell-matrix interactions. J Cell Biol. 1995;131:275–8.
3. Edwards DR, Handsley MM, Pennington CJ. The ADAM metalloproteinases. Mol Asp Med. 2008;29:258–89.
4. Duffy MJ, McKiernan E, O’Donovan N, McGowan PM. Role of ADAMs in cancer formation and progression. Clinic Cancer Res Off J Am Assoc Cancer Res. 2009;15:1140–4.
5. Alfandari D, McCusker C, Cousin H. Adam function in embryogenesis. Semin Cell Dev Biol. 2009;20:153–63.
6. Zhang J, Qi J, Chen N, Fu W, Zhou B, He A. High expression of a disintegrin and metalloproteinase-9 predicts a shortened survival time in completely resected stage I non-small cell lung cancer. Oncol Lett. 2013;5:1461–6.
7. Li J, Ji Z, Qiao C, Qi Y, Shi W. Overexpression of ADAM9 promotes colon cancer cells invasion. J Invest Surg. 2013.
8. Sung SY, Kubo H, Shigemura K, Arnold RS, Logani S, Wang R, et al. Oxidative stress induces ADAM9 protein expression in human prostate cancer cells. Cancer Res. 2006;66:9519–26.
9. Govoni KE, Amaar YG, Kramer A, Winter E, Baylink DJ, Mohan S. Regulation of insulin-like growth factor binding protein-5, four and a half lim-2, and a disintegrin and metalloprotease-9 expression in osteoblasts. Grow Horm IGF Res. 2006;16:49–56.
10. Mohan S, Thompson GR, Amaar YG, Hathaway G, Tschesche H, Baylink DJ. Adam-9 is an insulin-like growth factor binding protein-5 protease produced and secreted by human osteoblasts. Biochemistry. 2002;41:15394–403.
11. Bartel DP. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell. 2004;116:281–97.
12. Bartel DP. MicroRNAs: target recognition and regulatory functions. Cell. 2009;136:215–33.
13. Ebrahimi F, Gopalan V, Smith RA, Lam AK. miR-126 in human cancers: clinical roles and current perspectives. Exp Mol Pathol. 2014;96:98–107.
14. Namlos HM, Meza-Zepeda LA, Baroy T, Ostensen IH, Kresse SH, Kuijjer ML, et al. Modulation of the osteosarcoma expression phenotype by microRNAs. PLoS One. 2012;7:e48086.
15. Hamada S, Satoh K, Fujibuchi W, Hirota M, Kanno A, Unno J, et al. miR-126 acts as a tumor suppressor in pancreatic cancer cells via the regulation of ADAM9. Mol Cancer Res MCR. 2012;10:3–10.
16. Mazzocca A, Coppari R, De Franco R, Cho JY, Libermann TA, Pinzani M, et al. A secreted form of ADAM9 promotes carcinoma invasion through tumor-stromal interactions. Cancer Res. 2005;65:4728–38.
17. Zhang B, Pan X, Cobb GP, Anderson TA. MicroRNAs as oncogenes and tumor suppressors. Dev Biol. 2007;302:1–12.
18. Zhang H, Cai X, Wang Y, Tang H, Tong D, Ji F. MicroRNA-143, down-regulated in osteosarcoma, promotes apoptosis and suppresses tumorigenicity by targeting bcl-2. Oncol Rep. 2010;24:1363–9.
19. Liu LH, Li H, Li JP, Zhong H, Zhang HC, Chen J, et al. miR-125b suppresses the proliferation and migration of osteosarcoma cells through down-regulation of stat3. Biochem Biophys Res Commun. 2011;416:31–8.
20. Zhao H, Li M, Li L, Yang X, Lan G, Zhang Y. MiR-133b is down-regulated in human osteosarcoma and inhibits osteosarcoma cells proliferation, migration and invasion, and promotes apoptosis. PLoS One. 2013;8:e83571.
21. Wu X, Zhong D, Gao Q, Zhai W, Ding Z, Wu J. MicroRNA-34a inhibits human osteosarcoma proliferation by downregulating ether a go-go 1 expression. Int J Med Sci. 2013;10:676–82.
22. Xu JQ, Liu P, Si MJ, Ding XY. MicroRNA-126 inhibits osteosarcoma cells proliferation by targeting sirt1. Tumour Biol J Int Soc Oncodevelopment Biol Med. 2013;34:3871–7.
23. Yang C, Hou C, Zhang H, Wang D, Ma Y, Zhang Y, et al. miR-126 functions as a tumor suppressor in osteosarcoma by targeting sox2. Int J Mol Sci. 2014;15:423–37.
24. Liu Y, Zhou Y, Feng X, An P, Quan X, Wang H, et al. MicroRNA-126 functions as a tumor suppressor in colorectal cancer cells by targeting cxcr4 via the akt and erk1/2 signaling pathways. Int J Oncol. 2014;44:203–10.
25. Zhang Y, Yang P, Sun T, Li D, Xu X, Rui Y, et al. miR-126 and miR-126* repress recruitment of mesenchymal stem cells and inflammatory monocytes to inhibit breast cancer metastasis. Nat Cell Biol. 2013;15:284–94.